Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Precigen, Inc. Common Stock

PGEN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of PGEN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
PGEN Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
PGEN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
PGEN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in PGEN holdings by institutional investors

Quarterly net insider trading by PGEN's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for PGEN

Quiver Logo

No former government officials on record as having lobbied for PGEN

Revolving Door Dashboard

PGEN Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

PGEN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
PGEN Income Statement
PGEN Balance Sheet
PGEN Cash Flow
U.S. Patents

New PGEN patent grants

  • Patent Title: Fusion constructs and methods of using thereof Aug. 11, 2026
  • Patent Title: Electroporation apparatus and method Mar. 10, 2026
  • Patent Title: Cd33 specific chimeric antigen receptors Feb. 24, 2026
  • Patent Title: Human papillomavirus vaccines and uses of the same Sep. 02, 2025
  • Patent Title: Ror-1 specific chimeric antigen receptors and uses thereof Apr. 15, 2025
  • Patent Title: Methods and microorganisms for the fermentation of methane to multi-carbon compounds Feb. 25, 2025
  • Patent Title: Hepatitis b vaccines and uses of the same Feb. 25, 2025
  • Patent Title: Fusion constructs and methods of using thereof Jan. 14, 2025
  • Patent Title: Expression of novel cell tags Dec. 31, 2024
  • Patent Title: Molecular switches Sep. 17, 2024
  • Patent Title: Expression of novel cell tags Aug. 13, 2024
  • Patent Title: Methods and microorganisms for making 1,4-butanediol and derivatives thereof from c1 carbons Jun. 25, 2024
  • Patent Title: Frataxin expression constructs Jun. 04, 2024
  • Patent Title: Muc16 specific chimeric antigen receptors and uses thereof May. 14, 2024
  • Patent Title: Muc16 specific chimeric antigen receptors and uses thereof May. 07, 2024
  • Patent Title: Modulating expression of polypeptides via new gene switch expression systems Apr. 02, 2024
  • Patent Title: Methods and microorganisms for making 2,3-butanediol and derivatives thereof from c1 carbons Mar. 26, 2024
  • Patent Title: Biological production of multi-carbon compounds from methane Nov. 21, 2023
  • Patent Title: Cd33 specific chimeric antigen receptors Oct. 17, 2023
  • Patent Title: Polypeptide compositions comprising spacers Oct. 03, 2023
  • Patent Title: Modulating expression of polypeptides via new gene switch expression systems Jul. 04, 2023
  • Patent Title: Hepatitis b vaccines and uses of the same Mar. 21, 2023
  • Patent Title: Fusion constructs and methods of using thereof Dec. 27, 2022
  • Patent Title: Methods and microorganisms for the fermentation of methane to multi-carbon compounds Aug. 23, 2022
  • Patent Title: Muc16 specific chimeric antigen receptors and uses thereof May. 03, 2022
  • Patent Title: Molecular switches Dec. 14, 2021
  • Patent Title: Methods and microorganisms for making 1,4-butanediol and derivatives thereof from c1 carbons Oct. 26, 2021
  • Patent Title: Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies Oct. 26, 2021
  • Patent Title: Expression of novel cell tags Sep. 14, 2021
  • Patent Title: Frataxin expression constructs Sep. 14, 2021
  • Patent Title: Methods and microorganisms for making 2,3-butanediol and derivatives thereof from c1 carbons Sep. 07, 2021
  • Patent Title: Expression of novel cell tags Jun. 15, 2021
  • Patent Title: Biological production of multi-carbon compounds from methane Dec. 29, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to PGEN from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
PGEN News

Recent insights relating to PGEN

CNBC Recommendations

Recent picks made for PGEN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PGEN

PGEN Analyst Ratings

PGEN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
PGEN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $PGEN stock a Buy, Sell, or Hold?

  • What is the price target for $PGEN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

PGEN Top Shareholders
Shareholder
Shares Held
PGEN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $PGEN stock?

  • Who owns the most shares of $PGEN stock?

  • What funds own $PGEN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

PGEN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view PGEN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About PGEN

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

  • Address Germantown, MD
  • Market Cap 2.8 billion
  • Employees 47
  • Industrial Classification Pharmaceutical Preparations

Precigen, Inc. Common Stock (PGEN) Historical Stock Prices

Precigen, Inc. Common Stock (PGEN) closed at $7.70 on September 24, 2026. Over the past year its adjusted close ranged from $3.10 to $7.89. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month+5.77%
  • 3 months+39.49%
  • Year to date+84.21%
  • 1 year+99.48%
  • 3 years+474.63%
  • 5 years+45.56%
  • Max-67.57%
See every congressional and insider trade on the PGEN price chart

Quiver Premium charts PGEN's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 7.37 7.75 7.33 7.70 7.70 4,617,864
Sep 23, 2026 7.95 8.01 7.19 7.44 7.44 5,563,947
Sep 22, 2026 7.64 8.04 7.52 7.89 7.89 5,329,026
Sep 21, 2026 7.84 7.91 7.63 7.70 7.70 3,240,275
Sep 18, 2026 7.98 8.04 7.70 7.78 7.78 9,578,263
Sep 17, 2026 7.58 7.95 7.58 7.87 7.87 9,364,227
Sep 16, 2026 7.00 7.49 6.94 7.43 7.43 8,226,554
Sep 15, 2026 6.81 7.01 6.76 7.00 7.00 2,779,394
Sep 14, 2026 6.86 7.11 6.83 6.85 6.85 2,825,661
Sep 11, 2026 6.77 6.92 6.76 6.85 6.85 2,061,200
Sep 10, 2026 6.70 6.73 6.54 6.68 6.68 2,838,548
Sep 9, 2026 6.87 6.88 6.67 6.80 6.80 3,137,663
Sep 8, 2026 6.89 7.02 6.72 6.87 6.87 2,770,688
Sep 4, 2026 7.12 7.27 7.08 7.10 7.10 2,192,987
Sep 3, 2026 7.00 7.14 6.98 7.14 7.14 2,188,672
Sep 2, 2026 6.91 7.14 6.82 7.01 7.01 2,638,059
Sep 1, 2026 6.81 7.00 6.80 6.86 6.86 2,806,113
Aug 31, 2026 6.93 7.00 6.60 6.93 6.93 4,135,656
Aug 28, 2026 7.11 7.19 6.92 6.95 6.95 2,703,251
Aug 27, 2026 7.43 7.46 7.14 7.19 7.19 4,977,077
Aug 26, 2026 7.66 7.71 7.28 7.42 7.42 7,409,483
Aug 25, 2026 7.29 7.55 7.23 7.28 7.28 5,842,111
Aug 24, 2026 7.15 7.21 6.93 7.17 7.17 3,350,148
Aug 21, 2026 7.50 7.50 7.10 7.20 7.20 4,406,177
Aug 20, 2026 7.06 7.49 6.97 7.44 7.44 7,838,247
Aug 19, 2026 6.97 7.21 6.80 7.16 7.16 8,152,571
Aug 18, 2026 6.42 6.79 6.34 6.75 6.75 4,356,333
Aug 17, 2026 6.17 6.78 6.10 6.55 6.55 6,277,580
Aug 14, 2026 6.32 6.39 6.08 6.10 6.10 7,960,238
Aug 13, 2026 6.97 6.97 6.46 6.49 6.49 5,532,833
Aug 12, 2026 6.88 6.95 6.65 6.85 6.85 4,424,089
Aug 11, 2026 7.10 7.10 6.75 6.86 6.86 4,876,243
Aug 10, 2026 7.21 7.32 6.97 7.00 7.00 4,753,488
Aug 7, 2026 7.05 7.26 6.93 7.23 7.23 5,758,900
Aug 6, 2026 6.86 7.12 6.67 6.91 6.91 7,269,947
Aug 5, 2026 7.02 7.23 6.55 6.89 6.89 16,936,790
Aug 4, 2026 6.63 6.80 6.37 6.53 6.53 8,015,238
Aug 3, 2026 6.23 6.70 6.07 6.61 6.61 7,441,195
Jul 31, 2026 5.94 6.28 5.92 6.27 6.27 5,624,066
Jul 30, 2026 5.38 5.96 5.38 5.94 5.94 3,594,425
Jul 29, 2026 5.57 5.63 5.37 5.45 5.45 3,561,608
Jul 28, 2026 5.41 5.57 5.22 5.53 5.53 3,760,531
Jul 27, 2026 5.41 5.69 5.39 5.42 5.42 5,534,326
Jul 24, 2026 5.58 5.64 5.29 5.40 5.40 2,866,922
Jul 23, 2026 5.18 5.56 5.13 5.54 5.54 3,101,197
Jul 22, 2026 5.38 5.51 5.25 5.32 5.32 3,036,662
Jul 21, 2026 5.12 5.59 5.11 5.49 5.49 4,384,642
Jul 20, 2026 4.95 5.08 4.89 5.07 5.07 3,485,763
Jul 17, 2026 4.87 5.04 4.81 4.95 4.95 2,967,831
Jul 16, 2026 5.02 5.10 4.89 4.95 4.95 3,943,713
Jul 15, 2026 5.13 5.14 5.01 5.12 5.12 1,917,884
Jul 14, 2026 5.18 5.22 5.00 5.12 5.12 2,904,684
Jul 13, 2026 5.25 5.26 5.04 5.17 5.17 3,042,726
Jul 10, 2026 5.50 5.50 5.17 5.32 5.32 3,455,433
Jul 9, 2026 5.56 5.68 5.47 5.53 5.53 2,989,087
Jul 8, 2026 5.40 5.68 5.38 5.56 5.56 3,738,939
Jul 7, 2026 5.63 5.79 5.43 5.51 5.51 7,508,520
Jul 6, 2026 5.58 5.79 5.39 5.60 5.60 5,158,293
Jul 2, 2026 5.33 5.66 5.25 5.64 5.64 4,766,167
Jul 1, 2026 5.65 5.67 5.20 5.25 5.25 7,609,982
Jun 30, 2026 5.92 5.97 5.62 5.70 5.70 4,217,181
Jun 29, 2026 5.89 6.04 5.74 5.92 5.92 6,288,182
Jun 26, 2026 5.50 5.95 5.48 5.86 5.86 11,313,031
Jun 25, 2026 5.61 5.68 5.43 5.52 5.52 5,354,637
Jun 24, 2026 5.43 5.61 5.26 5.40 5.40 5,606,434
Jun 23, 2026 5.29 5.59 5.26 5.36 5.36 5,246,932
Jun 22, 2026 4.89 5.39 4.89 5.38 5.38 8,546,937
Jun 18, 2026 4.76 4.87 4.59 4.82 4.82 4,755,744
Jun 17, 2026 4.76 4.90 4.71 4.73 4.73 3,834,276
Jun 16, 2026 4.81 4.85 4.65 4.75 4.75 3,576,790
Jun 15, 2026 4.60 4.80 4.43 4.80 4.80 6,770,942
Jun 12, 2026 4.57 4.71 4.41 4.45 4.45 4,562,399
Jun 11, 2026 3.89 4.58 3.80 4.53 4.53 9,956,279
Jun 10, 2026 3.70 3.98 3.70 3.89 3.89 4,243,869
Jun 9, 2026 3.66 3.75 3.56 3.71 3.71 3,545,656
Jun 8, 2026 3.59 3.68 3.51 3.57 3.57 4,631,205
Jun 5, 2026 3.84 3.88 3.53 3.58 3.58 5,330,704
Jun 4, 2026 3.83 3.94 3.77 3.86 3.86 4,089,899
Jun 3, 2026 3.86 3.90 3.69 3.81 3.81 7,793,884
Jun 2, 2026 4.08 4.10 3.78 3.86 3.86 9,639,313
Jun 1, 2026 4.28 4.40 4.11 4.12 4.12 4,835,655
May 29, 2026 4.49 4.58 4.33 4.34 4.34 5,544,091
May 28, 2026 4.51 4.68 4.35 4.51 4.51 5,692,401
May 27, 2026 4.24 4.40 4.11 4.40 4.40 5,752,758
May 26, 2026 4.29 4.37 4.14 4.24 4.24 6,099,106
May 22, 2026 4.24 4.36 4.20 4.24 4.24 1,713,082
May 21, 2026 4.18 4.30 4.12 4.28 4.28 2,242,403
May 20, 2026 4.21 4.37 4.19 4.27 4.27 3,104,750
May 19, 2026 4.05 4.25 3.98 4.16 4.16 2,957,145
May 18, 2026 4.42 4.46 3.95 4.07 4.07 5,177,867
May 15, 2026 4.54 4.63 4.36 4.42 4.42 3,615,522
May 14, 2026 4.58 4.87 4.32 4.60 4.60 9,730,900
May 13, 2026 4.07 4.22 4.04 4.15 4.15 2,763,545
May 12, 2026 4.16 4.18 4.02 4.08 4.08 2,322,186
May 11, 2026 4.28 4.34 4.19 4.20 4.20 1,945,090
May 8, 2026 4.18 4.24 4.11 4.21 4.21 4,873,575
May 7, 2026 4.40 4.40 4.09 4.15 4.15 3,220,647
May 6, 2026 4.29 4.40 4.19 4.40 4.40 3,739,392
May 5, 2026 4.21 4.41 4.17 4.33 4.33 3,866,151
May 4, 2026 4.06 4.14 4.03 4.14 4.14 2,279,286
May 1, 2026 4.13 4.18 4.06 4.08 4.08 1,756,421
Apr 30, 2026 4.09 4.24 4.08 4.16 4.16 2,515,682
Apr 29, 2026 3.96 4.20 3.92 4.12 4.12 2,904,174
Apr 28, 2026 3.96 4.10 3.93 4.02 4.02 1,832,441
Apr 27, 2026 4.10 4.24 3.96 3.96 3.96 2,802,093
Apr 24, 2026 4.00 4.26 3.95 4.13 4.13 3,459,299
Apr 23, 2026 3.97 4.05 3.84 3.96 3.96 4,996,132
Apr 22, 2026 4.02 4.05 3.91 3.96 3.96 1,640,417
Apr 21, 2026 4.09 4.12 3.94 3.98 3.98 1,653,435
Apr 20, 2026 3.99 4.30 3.98 4.11 4.11 3,671,031
Apr 17, 2026 4.04 4.05 3.91 3.98 3.98 2,504,425
Apr 16, 2026 3.92 3.96 3.80 3.95 3.95 2,355,673
Apr 15, 2026 3.96 3.98 3.87 3.90 3.90 2,671,798
Apr 14, 2026 4.17 4.28 3.91 3.98 3.98 4,185,551
Apr 13, 2026 4.16 4.26 4.09 4.17 4.17 1,703,271
Apr 10, 2026 4.30 4.37 4.07 4.16 4.16 2,826,565
Apr 9, 2026 4.06 4.29 4.02 4.27 4.27 2,596,145
Apr 8, 2026 4.28 4.34 4.01 4.12 4.12 5,499,711
Apr 7, 2026 4.11 4.20 3.95 4.12 4.12 2,787,909
Apr 6, 2026 3.95 4.20 3.92 4.19 4.19 3,706,862
Apr 2, 2026 3.86 4.03 3.75 3.94 3.94 5,457,993
Apr 1, 2026 3.81 4.06 3.78 3.93 3.93 5,748,245
Mar 31, 2026 3.29 3.98 3.29 3.87 3.87 12,564,475
Mar 30, 2026 3.61 3.67 3.22 3.25 3.25 13,128,048
Mar 27, 2026 3.80 4.00 3.62 3.67 3.67 7,072,388
Mar 26, 2026 4.07 4.28 3.73 3.89 3.89 23,541,517
Mar 25, 2026 3.10 3.25 3.04 3.10 3.10 6,729,079
Mar 24, 2026 3.20 3.23 3.05 3.13 3.13 5,344,795
Mar 23, 2026 3.34 3.37 3.23 3.24 3.24 3,155,878
Mar 20, 2026 3.26 3.38 3.23 3.28 3.28 3,163,443
Mar 19, 2026 3.24 3.36 3.11 3.32 3.32 4,021,628
Mar 18, 2026 3.48 3.54 3.27 3.27 3.27 4,022,065
Mar 17, 2026 3.51 3.57 3.46 3.54 3.54 1,706,451
Mar 16, 2026 3.55 3.64 3.50 3.51 3.51 1,810,338
Mar 13, 2026 3.32 3.55 3.32 3.51 3.51 2,802,079
Mar 12, 2026 3.41 3.41 3.25 3.28 3.28 2,274,473
Mar 11, 2026 3.43 3.50 3.37 3.42 3.42 1,962,030
Mar 10, 2026 3.56 3.59 3.44 3.51 3.51 2,338,438
Mar 9, 2026 3.29 3.53 3.28 3.51 3.51 2,560,129
Mar 6, 2026 3.26 3.34 3.22 3.32 3.32 2,406,193
Mar 5, 2026 3.45 3.48 3.26 3.37 3.37 4,996,646
Mar 4, 2026 3.40 3.56 3.29 3.55 3.55 4,587,876
Mar 3, 2026 3.50 3.58 3.37 3.38 3.38 6,053,411
Mar 2, 2026 3.65 3.79 3.55 3.62 3.62 7,935,085
Feb 27, 2026 3.71 3.95 3.70 3.79 3.79 3,203,685
Feb 26, 2026 3.84 3.85 3.63 3.81 3.81 7,887,496
Feb 25, 2026 4.00 4.09 3.84 3.84 3.84 3,801,336
Feb 24, 2026 4.08 4.26 3.94 3.98 3.98 5,850,065
Feb 23, 2026 4.31 4.42 4.04 4.08 4.08 7,356,936
Feb 20, 2026 4.45 4.60 4.31 4.38 4.38 6,025,883
Feb 19, 2026 4.85 4.85 4.34 4.51 4.51 6,038,730
Feb 18, 2026 5.18 5.23 4.65 4.88 4.88 6,315,318
Feb 17, 2026 4.86 5.46 4.82 5.21 5.21 9,016,465
Feb 13, 2026 4.79 4.95 4.68 4.93 4.93 2,409,774
Feb 12, 2026 4.95 5.00 4.63 4.74 4.74 2,524,901
Feb 11, 2026 4.61 4.94 4.41 4.91 4.91 3,977,387
Feb 10, 2026 4.70 4.72 4.53 4.66 4.66 3,436,845
Feb 9, 2026 4.31 4.60 4.12 4.56 4.56 3,980,694
Feb 6, 2026 4.28 4.46 4.28 4.29 4.29 3,843,791
Feb 5, 2026 4.49 4.60 4.22 4.24 4.24 3,736,702
Feb 4, 2026 4.79 4.90 4.45 4.56 4.56 3,296,145
Feb 3, 2026 4.88 5.02 4.59 4.80 4.80 2,665,685
Feb 2, 2026 4.44 4.86 4.37 4.83 4.83 2,505,869
Jan 30, 2026 4.60 4.88 4.39 4.49 4.49 3,456,224
Jan 29, 2026 4.44 4.62 4.30 4.53 4.53 2,586,471
Jan 28, 2026 4.92 4.92 4.41 4.46 4.46 2,786,982
Jan 27, 2026 4.75 4.88 4.67 4.73 4.73 2,303,912
Jan 26, 2026 4.70 4.80 4.38 4.75 4.75 3,453,540
Jan 23, 2026 4.90 5.10 4.59 4.76 4.76 4,851,027
Jan 22, 2026 4.46 4.96 4.46 4.84 4.84 7,775,482
Jan 21, 2026 4.31 4.48 4.25 4.46 4.46 2,391,962
Jan 20, 2026 4.35 4.57 4.20 4.39 4.39 3,018,486
Jan 16, 2026 4.31 4.45 4.12 4.41 4.41 3,636,911
Jan 15, 2026 4.41 4.44 4.03 4.14 4.14 3,866,482
Jan 14, 2026 4.16 4.48 4.10 4.41 4.41 3,614,375
Jan 13, 2026 4.15 4.21 3.93 4.17 4.17 3,414,529
Jan 12, 2026 4.53 4.59 4.09 4.13 4.13 5,971,957
Jan 9, 2026 4.62 4.76 4.58 4.59 4.59 3,534,946
Jan 8, 2026 4.76 4.82 4.38 4.61 4.61 3,862,178
Jan 7, 2026 4.64 4.95 4.57 4.85 4.85 5,033,817
Jan 6, 2026 4.17 4.57 4.14 4.55 4.55 3,929,534
Jan 5, 2026 4.32 4.38 4.01 4.18 4.18 3,485,140
Jan 2, 2026 4.19 4.35 4.11 4.28 4.28 2,777,919
Dec 31, 2025 4.23 4.31 4.14 4.18 4.18 3,975,450
Dec 30, 2025 4.42 4.43 4.17 4.26 4.26 3,170,618
Dec 29, 2025 4.15 4.53 4.15 4.45 4.45 6,311,905
Dec 26, 2025 4.17 4.24 4.05 4.16 4.16 2,816,841
Dec 24, 2025 4.06 4.23 4.06 4.19 4.19 2,615,671
Dec 23, 2025 4.17 4.30 3.96 4.07 4.07 4,909,976
Dec 22, 2025 4.47 4.54 4.18 4.38 4.38 8,655,756
Dec 19, 2025 4.22 4.53 4.12 4.32 4.32 23,042,128
Dec 18, 2025 4.00 4.26 3.90 4.17 4.17 5,908,375
Dec 17, 2025 3.96 4.08 3.78 3.98 3.98 9,324,721
Dec 16, 2025 3.78 3.96 3.64 3.87 3.87 5,942,198
Dec 15, 2025 3.69 3.91 3.65 3.81 3.81 4,224,142
Dec 12, 2025 3.64 3.73 3.48 3.69 3.69 3,729,659
Dec 11, 2025 3.53 3.75 3.52 3.62 3.62 2,243,731
Dec 10, 2025 3.50 3.70 3.42 3.51 3.51 3,922,012
Dec 9, 2025 3.68 3.76 3.49 3.51 3.51 2,355,194
Dec 8, 2025 3.69 3.76 3.63 3.69 3.69 1,733,306
Dec 5, 2025 3.79 3.85 3.60 3.60 3.60 3,108,844
Dec 4, 2025 3.57 3.81 3.51 3.75 3.75 1,906,872
Dec 3, 2025 3.48 3.58 3.46 3.57 3.57 2,622,261
Dec 2, 2025 3.60 3.63 3.44 3.48 3.48 2,563,328
Dec 1, 2025 3.86 3.86 3.57 3.61 3.61 3,151,292
Nov 28, 2025 3.77 3.92 3.71 3.83 3.83 1,777,771
Nov 26, 2025 3.65 3.79 3.54 3.74 3.74 3,300,402
Nov 25, 2025 3.83 3.83 3.62 3.67 3.67 2,756,577
Nov 24, 2025 3.88 4.01 3.81 3.82 3.82 6,546,780
Nov 21, 2025 3.87 4.06 3.71 3.88 3.88 4,627,676
Nov 20, 2025 4.28 4.49 3.88 3.90 3.90 5,307,731
Nov 19, 2025 4.79 4.81 4.21 4.22 4.22 5,275,998
Nov 18, 2025 4.92 5.00 4.76 4.85 4.85 4,383,105
Nov 17, 2025 4.84 5.00 4.71 4.90 4.90 5,461,762
Nov 14, 2025 3.78 5.19 3.74 4.85 4.85 16,790,982
Nov 13, 2025 4.00 4.05 3.77 3.86 3.86 3,930,696
Nov 12, 2025 3.97 4.04 3.74 4.02 4.02 3,996,736
Nov 11, 2025 4.00 4.03 3.82 3.96 3.96 3,791,170
Nov 10, 2025 3.97 4.04 3.87 4.00 4.00 2,858,601
Nov 7, 2025 3.90 3.94 3.62 3.90 3.90 3,371,435
Nov 6, 2025 3.97 3.98 3.79 3.92 3.92 2,936,828
Nov 5, 2025 3.89 4.13 3.89 3.99 3.99 4,802,953
Nov 4, 2025 4.02 4.15 3.85 3.88 3.88 2,400,414
Nov 3, 2025 4.13 4.35 4.04 4.16 4.16 5,668,849
Oct 31, 2025 4.04 4.15 3.95 4.14 4.14 6,397,186
Oct 30, 2025 3.93 4.08 3.93 4.05 4.05 2,070,928
Oct 29, 2025 4.05 4.09 3.94 4.01 4.01 2,138,103
Oct 28, 2025 4.28 4.35 3.96 4.06 4.06 2,699,747
Oct 27, 2025 4.40 4.42 4.19 4.30 4.30 2,793,947
Oct 24, 2025 4.33 4.51 4.28 4.33 4.33 3,742,561
Oct 23, 2025 3.88 4.27 3.88 4.25 4.25 6,528,672
Oct 22, 2025 4.12 4.18 3.85 3.91 3.91 4,317,429
Oct 21, 2025 3.93 4.24 3.91 4.08 4.08 3,947,243
Oct 20, 2025 4.02 4.20 3.90 3.94 3.94 4,689,775
Oct 17, 2025 3.44 4.04 3.39 4.00 4.00 11,967,464
Oct 16, 2025 3.59 3.62 3.43 3.49 3.49 4,860,493
Oct 15, 2025 3.25 3.55 3.20 3.53 3.53 5,675,864
Oct 14, 2025 3.16 3.29 3.11 3.20 3.20 4,200,651
Oct 13, 2025 3.28 3.29 3.06 3.21 3.21 5,746,241
Oct 10, 2025 3.22 3.22 2.99 3.12 3.12 7,964,412
Oct 9, 2025 3.19 3.22 3.08 3.19 3.19 3,351,213
Oct 8, 2025 3.33 3.42 3.21 3.22 3.22 5,177,161
Oct 7, 2025 3.14 3.33 3.08 3.31 3.31 4,911,786
Oct 6, 2025 3.32 3.32 3.12 3.14 3.14 4,092,329
Oct 3, 2025 3.38 3.38 3.19 3.25 3.25 3,743,007
Oct 2, 2025 3.38 3.42 3.26 3.33 3.33 4,624,036
Oct 1, 2025 3.27 3.49 3.27 3.34 3.34 4,372,910
Sep 30, 2025 3.61 3.73 3.28 3.29 3.29 7,043,417
Sep 29, 2025 3.62 3.73 3.53 3.63 3.63 3,477,192
Sep 26, 2025 3.48 3.54 3.37 3.51 3.51 4,357,772
Sep 25, 2025 3.75 3.76 3.47 3.48 3.48 5,952,896
Sep 24, 2025 3.76 4.00 3.73 3.86 3.86 8,072,469

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Precigen, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at PGEN, per a recent SEC DEF 14A filing. We estimate that the median employee at PRECIGEN, INC. is paid $155,000.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation